Stock GSL GREEN SCIENTIFIC LABS HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Green Scientific Labs Holdings Inc.

Equities

GSL

CA39337P1062

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange
Other stock markets
 03:43:50 2023-09-05 pm EDT 		5-day change 1st Jan Change
0.055 CAD +120.00% Intraday chart for Green Scientific Labs Holdings Inc. -.--% -.--%
2023 ACT Laboratories, Inc. completed the acquisition of Florida operations from Green Scientific Labs Holdings Inc.. CI
2023 Green Scientific Labs Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 83.83 0.1565
Enterprise Value (EV) 1 84.63 1.959
P/E ratio -5.27 x -0.01 x
Yield - -
Capitalization / Revenue 11 x 0.06 x
EV / Revenue 11.1 x 0.79 x
EV / EBITDA -25.1 x -0.5 x
EV / FCF -20,428,013 x -1,492,951 x
FCF Yield -0% -0%
Price to Book 9.02 x -0.62 x
Nbr of stocks (in thousands) 21,199 21,224
Reference price 2 3.955 0.007375
Announcement Date 5/2/22 5/1/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 3.62 6.096 7.591 2.472
EBITDA 1 0.7198 -0.002337 -3.37 -3.929
EBIT 1 0.6118 -0.3328 -3.85 -4.905
Operating Margin 16.9% -5.46% -50.71% -198.45%
Earnings before Tax (EBT) 1 0.2977 -0.9107 -8.524 -6.886
Net income 1 0.2977 -0.9107 -8.524 -9.836
Net margin 8.23% -14.94% -112.29% -397.99%
EPS - -0.0911 -0.7500 -0.6622
Free Cash Flow - -0.2694 -4.143 -1.312
FCF margin - -4.42% -54.57% -53.08%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 11/15/21 11/15/21 5/2/22 5/1/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 1.11 2.66 0.8 1.8
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 1.547 x -1,138 x -0.2368 x -0.4586 x
Free Cash Flow - -0.27 -4.14 -1.31
ROE (net income / shareholders' equity) - -165% -174% -152%
ROA (Net income/ Total Assets) - -5.42% -22% -26.4%
Assets 1 - 16.81 38.66 37.26
Book Value Per Share - 0.0500 0.4400 -0.0100
Cash Flow per Share - 0.0200 0.2400 0.0200
Capex 1 1.21 0.39 2.86 0.87
Capex / Sales 33.46% 6.4% 37.68% 35.37%
Announcement Date 11/15/21 11/15/21 5/2/22 5/1/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
GREEN SCIENTIFIC LABS HOLDINGS INC. Stock Green Scientific Labs Holdings Inc.
-.--% 855K
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-16.55% 8.43B
RADNET, INC. Stock RadNet, Inc.
+40.93% 3.62B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-35.59% 2.61B
SYNLAB AG Stock SYNLAB AG
-7.88% 2.48B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-8.00% 2.34B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-5.93% 1.94B
FLEURY S.A. Stock Fleury S.A.
-18.96% 1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-38.35% 1.26B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+6.91% 1.1B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. GSL Stock
  4. Financials Green Scientific Labs Holdings Inc.